patient
febril
ill
present
ebola
treatment
unit
sierra
leon
wide
rang
diagnos
ebola
viru
diseas
rapid
diagnost
test
use
confirm
diagnos
reduc
length
patient
stay
valuabl
consequ
altern
diagnos
assist
futur
plan
current
epidem
ebola
viru
diseas
evd
west
africa
largest
complex
histori
may
case
report
across
guinea
liberia
sierra
leon
result
death
key
part
unit
kingdom
respons
crisi
sierra
leon
build
sever
treatment
center
provid
bed
treatment
evd
patient
addit
british
defenc
medic
servic
dm
establish
militari
evd
treatment
unit
evdtu
kerri
town
provid
medic
care
healthcar
worker
hcw
evd
unit
staf
militari
clinician
nurs
healthcar
assist
support
wellresourc
onsit
laboratori
public
health
england
provid
ebola
viru
ebov
diagnost
realtim
quantit
revers
transcriptas
polymeras
chain
reaction
rtpcr
militari
laboratori
capabl
includ
hematolog
clot
clinic
chemistri
test
alongsid
autom
blood
cultur
system
rapid
diagnost
test
rdt
malaria
dengu
human
immunodefici
viru
hiv
togeth
biofir
filmarray
blood
cultur
identif
respiratori
rp
gastrointestin
gi
panel
latter
provid
result
clinic
sampl
includ
whole
blood
nasopharyng
np
swab
rectal
swab
stool
sampl
within
minut
collect
multiplex
pcr
recent
week
outbreak
number
new
case
evd
declin
howev
nation
intern
hcw
may
present
nonspecif
symptom
consist
varieti
diagnos
includ
evd
incub
period
ebov
day
current
guidelin
recommend
ebov
rtpcr
repeat
patient
hour
symptom
onset
first
test
neg
howev
may
instanc
care
assess
individu
histori
indic
low
risk
evd
abil
reach
altern
nonevd
diagnosi
within
hour
symptom
onset
support
clinic
acumen
relev
laboratori
find
import
risk
treatment
implic
patient
treatment
unit
capac
individu
employ
organ
describ
use
rdt
particularli
filmarray
focus
patientspecif
manner
assist
situat
conduct
anonym
retrospect
review
clinic
laboratori
data
collect
cours
routin
patient
care
patient
admit
dm
evdtu
includ
nation
intern
hcw
care
evdposit
patient
local
nation
also
refer
admit
casebycas
basi
patient
admit
directli
commun
other
transfer
neighbor
treatment
center
case
definit
admiss
acut
fever
histori
fever
headach
gener
pain
fatigu
nausea
vomit
anorexia
diarrhea
abdomin
pain
dysphagia
difficulti
breath
hiccup
miscarriag
person
unexplain
bleed
follow
admiss
blood
sampl
collect
test
either
onsit
laboratori
use
bedsid
istat
abbott
point
care
former
avail
rdt
exclud
malaria
also
perform
admiss
binaxnow
dengu
sd
biolin
dengu
duo
hiv
aler
determin
rdt
perform
clinic
indic
ebov
rtpcr
perform
patient
confirmatori
test
perform
patient
posit
result
anoth
facil
among
patient
risk
assess
histori
andor
examin
suggest
evd
particular
symptom
upper
respiratori
tract
infect
urti
enter
infect
investig
perform
filmarray
panel
consist
enclos
pouch
fulli
autom
nucleic
acid
extract
revers
transcript
amplif
analysi
biofir
diagnost
salt
lake
citi
utah
rp
filmarray
panel
detect
sever
virus
bacteria
pathogen
detect
gi
filmarray
panel
includ
bacteria
sever
diarrheagen
escherichia
coli
parasit
virus
np
swab
rectalfec
swab
process
accord
manufactur
instruct
test
consid
valid
complet
normal
intern
control
pass
either
control
fail
invalid
result
report
panel
analyt
otherwis
autom
result
analysi
target
valid
test
report
detect
detect
simpl
oneway
analysi
varianc
broad
diagnost
group
malaria
np
gi
filmarray
undifferenti
febril
ill
ufi
diagnos
calcul
use
bonferroni
multipl
comparison
test
signific
spss
statist
novemb
februari
individu
admit
dm
evdtu
among
diagnos
evd
intern
hcw
report
exposur
ebov
repatri
host
nation
among
nonevd
diagnos
male
mean
age
year
rang
thirtytwo
nonsierra
leonean
nation
europ
north
america
hcw
predominantli
physician
nurs
within
nonevd
group
categori
diagnos
tabl
malaria
diagnos
quarter
patient
singl
infect
plasmodium
falciparum
predomin
case
similar
proport
nonevd
diagnos
due
gastrointestin
infect
identifi
gi
filmarray
among
enter
pathogen
occur
individu
typic
diarrheagen
e
coli
shigella
speci
diagnos
next
frequent
made
base
histori
clinic
examin
support
hematolog
clinic
chemistri
find
absenc
investig
avail
eg
radiolog
ufi
diagnos
patient
fever
featur
present
without
clear
focu
infect
avail
diagnost
test
neg
symptom
resolv
discharg
final
urti
support
posit
np
filmarray
virus
diagnos
patient
tabl
hiv
identifi
patient
occur
coinfect
case
falciparum
malaria
anoth
lower
respiratori
tract
infect
three
individu
sierra
leon
one
kenya
patient
length
stay
lo
diagnost
group
vari
tabl
median
lo
ufi
diagnos
day
interquartil
rang
iqr
n
wherea
day
malaria
iqr
n
day
diagnos
use
np
gi
filmarray
iqr
n
p
divers
diagnos
made
reflect
heterogen
patient
includ
signific
number
intern
hcw
perhap
unsurpris
patient
ufi
diagnosi
greater
lo
altern
diagnosi
neg
ebov
rtpcr
hour
symptom
onset
requir
discharg
evdtu
sierra
leon
give
empir
antimalari
treatment
patient
due
patient
popul
perform
malaria
rdt
new
admiss
treat
accordingli
rdt
sensit
easi
safe
use
cost
effect
malaria
diagnos
nonevd
case
consid
approach
appropri
strategi
provid
reason
altern
diagnosi
evd
avoid
unnecessari
treatment
although
median
lo
individu
malaria
day
upper
rang
hour
longer
patient
filmarray
diagnosi
due
perform
ebov
rtpcr
hour
symptom
onset
patient
malaria
endem
countri
due
high
rate
evd
malaria
coinfect
commerci
avail
multiplex
molecular
techniqu
identifi
respiratori
enter
pathogen
signific
advanc
laboratori
diagnost
biofir
filmarray
perhap
easiest
use
minim
handson
process
rapid
gener
result
inclus
extens
divers
spectrum
pathogen
target
high
sensit
specif
report
howev
filmarray
assay
lowthroughput
one
test
perform
per
instrument
per
hour
servic
provid
must
consid
system
appropri
patient
popul
laboratori
sever
limit
studi
first
cohort
rel
small
period
review
restrict
singl
season
may
influenc
number
type
activ
certain
pathogen
second
limit
particular
patient
popul
although
reflect
multin
hcw
patient
refer
facil
third
confound
factor
may
relationship
time
symptom
onset
patient
present
influenc
discharg
decis
final
note
caution
must
appli
regard
molecular
test
result
distinguish
live
dead
organ
demonstr
antimicrobi
sensit
identifi
presenc
pathogen
confirm
infect
asymptomat
individu
may
shed
organ
prolong
period
howev
use
filmarray
target
manner
patient
symptom
consist
activ
infect
may
account
high
number
posit
low
number
neg
result
observ
result
must
interpret
appropri
clinic
context
clinic
microbiolog
advic
particularli
multiplex
system
identifi
sever
pathogen
vari
signific
report
uniqu
describ
spectrum
nonevd
diagnos
observ
evdtu
use
rdt
particularli
novel
molecular
techniqu
support
diagnos
use
target
clinic
scenario
appropri
interpret
result
biofir
filmarray
ideal
system
proven
valuabl
diagnost
tool
resourcelimit
set
understand
caus
nonevd
ill
import
plan
futur
laboratori
support
evdtu
staff
health
protect
measur
eg
influenza
vaccin
malaria
chemoprophylaxi
studi
warrant
determin
applic
find
evd
outbreak
differ
context
may
also
relev
clinic
set
infecti
pathogen
potenti
conflict
interest
author
potenti
conflict
interest
author
submit
icmj
form
disclosur
potenti
conflict
interest
conflict
editor
consid
relev
content
manuscript
disclos
